dr gilda tachedjian molecular interactions group dec 2006

Proteomics and Rational Proteomics and Rational

Drug DesignDrug Design

Dr Gilda TachedjianMolecular Interactions Group

Dec 2006

Topics to be Covered in this PresentationTopics to be Covered in this Presentation

What is Proteomics?What is Proteomics?

Tools used to study the Proteome.Tools used to study the Proteome.

Application in medical diagnosisApplication in medical diagnosis

Application in rationale drug design.Application in rationale drug design.

Application in vaccinesApplication in vaccines

What is Proteomics?What is Proteomics? Proteome:

The complete set of proteins in existence in an organism throughout its life cycle, OR on a smaller scale the entirety of proteins found in a particular cell type under a particular type of stimulation

Proteomics: Study of the ProteomeThe effort to establish the identities, quantities, structure, and biochemical and cellular functions of complete complements of proteins in an organism, organ or organelles and how these properties vary in space, time and/or physiological state.

Proteome:The complete set of proteins in existence in an organism throughout its life cycle, OR on a smaller scale the entirety of proteins found in a particular cell type under a particular type of stimulation

Proteomics: Study of the ProteomeThe effort to establish the identities, quantities, structure, and biochemical and cellular functions of complete complements of proteins in an organism, organ or organelles and how these properties vary in space, time and/or physiological state.

GENEGENE

GENOMEGENOME

mRNAmRNA

TRANSCRIPTOMETRANSCRIPTOME PROTEOMEPROTEOME

PROTEINPROTEIN

Traditional

Contemporary

Gene AlternativeSplicing

CovalentModification

New ParadigmNew Paradigm

20,000 to 25,000 genesin human genome

1,000,000 proteins inhuman proteome

GENOMEGENOME

TRANSCRIPTOMETRANSCRIPTOME

PROTEOMEPROTEOME

Information Obtained from Genomic & Proteomic Analysis

Sequencing

DNA Microarrays

Mass spectrometryProtein arrays/chips

Gene identificationGene structureSNP (single nucleotidepolymorphism)Predict protein structure

Gene expression patternsin normal and diseasedtissue

Protein identificationProtein quantitationPost-translational modificationProtein-protein interaction

Need for ProteomicsNeed for Proteomics

Functions of proteins depends on the structure and interaction, which cannot be predicted accurately from sequence information.Abundance of a given RNA transcript may not reflect the abundance of the corresponding protein.Protein diversity is generated post-transcriptionally.Protein activity often depends on post-translational modifications, which are not predictable from the level of corresponding mRNA.The function of a protein often depends on its localization.Proteins are the most therapeutically relevant molecules.

A single genome can hypothetically give rise to an infinite number of qualitatively and quantitatively different proteomes.

The advantage of the proteome analysis rests with the ability to monitor :

effect of stage of the cell cycle;effect of growth effect of nutrient conditionseffect of temperature & stress responses

pathological changes…etc

Significance of ProteomicsSignificance of Proteomics

Proteins are the commercial endpoints of most research in the Biological/Biomedical Sciences.

Proteins carry out nearly all controlled biological functions.

Protein-protein interactions control most cellular processes.

Most diseases are treated at the protein level.

Proteins are extremely valuable products for the pharmaceutical, food, environmental and related biotechnological industries.

What does Proteomics study?

Protein and subcellular localization Protein function andinteractions

Key Technologies in ProteomicsKey Technologies in Proteomics

Protein SeparationProtein Separation

Electrophoretic techniques1D Gel Electrophoresis (separation on size)2D Gel Electrophoresis (separation on charge and size)

Chromatographic techniquesLiquid Chromatography (size separation)

Electrophoretic techniques1D Gel Electrophoresis (separation on size)2D Gel Electrophoresis (separation on charge and size)

Chromatographic techniquesLiquid Chromatography (size separation)

Reproducible separation & characterisation of large numbers of proteins from complex biological mixtures.

Protein Separation: 2D SDS-PAGE1st Dimension

Isoelectric Focusing (IEF)Equilibration

SDS-PAGE2nd Dimension

Reduction/AlkylationAnode (+)

Cathod (-)

3

10

pHProtein separatedbased on electriccharge in a pH gradient - protein stops migrating in gel whenreaches isoelectric point(i.e. not charged)

Cut Out Protein from 2D GelCut Out Protein from 2D Gel

Camera and Camera and light assemblylight assembly

Gel trayGel tray

Rinse stationRinse station

RacksRacks

Picker headPicker head

Mass Spectrometry Analysis of Mass Spectrometry Analysis of Tryptic Peptide Fragments Tryptic Peptide Fragments

Mass Spectrometry Analysis of Mass Spectrometry Analysis of Tryptic Peptide Fragments Tryptic Peptide Fragments

NN

CC

Electric field accelerates ion - lighter ions(if have same charge) reach detector first

m/z

Peptide Mapping and Mass Fingerprint by MALDI-TOF

The most commonly used technique (MALDI =matrix assisted laser desorption ionization; TOF=time of flight)

Proteins are identified by matching a list of experimental peptide masses with the calculated list of all peptides masses of each entry in a proteomics databases.

Mass mapping require a purified protein the technique is generally used in conjunction with prior protein fractionation

Research:Studies of basic Studies of basic cell function cell function

and molecular organisationand molecular organisation The discovery ofThe discovery of novel drug targetsnovel drug targets

i.e. Tamiflu and i.e. Tamiflu and Relenza for Influenza Relenza for Influenza

VirusVirusThe discovery of The discovery of molecular molecular

markers (biomarkers) for markers (biomarkers) for diagnosis anddiagnosis and

monitoring diseasemonitoring diseasei.i.e. prostate specific antigen e. prostate specific antigen

in blood as marker for in blood as marker for prostate cancerprostate cancer

What can Proteomics be used for:

The discovery ofThe discovery ofantigens expressed antigens expressed in cancer cells that in cancer cells that can be targeted for can be targeted for

vaccines vaccines developmentdevelopment

Biomarker Discovery ProcessBiomarker Discovery Process

Discovery Characterization Validation

Rapid ScreeningProtein Diff. Display

Biological FluidsCell / Bact. LysatesWhole Cells (LCM)

Digest Map Profiling

Partial Sequence Det.

Post-Translational Mods.

Data Base Mining

I.D. of Known Protein

I.D. of Novel Protein

Throughput

Intensive

Antibody Valid.

Phage Display

Discovery Characterization Validation

Rapid ScreeningProtein Diff. Display

Biological FluidsCell / Bact. LysatesWhole Cells (LCM)

Digest Map Profiling

Partial Sequence Det.

Post-Translational Mods.

Data Base Mining

I.D. of Known Protein

I.D. of Novel Protein

Throughput

Intensive

Antibody Valid.

Phage Display

Cancer Development and ProgressionCancer Development and Progression

Role of serum markers in cancer

I. Early diagnosis & differential diagnosis of space-occupying lesions.

II. Follow-up & therapeutic outcome & early detection of relapse.

III. Assessment of biological malignancy and prognosis.

IV. Selection of therapeutic interventions.V. Monitoring the patients who are at risk

of developing cancer.

Role of serum markers in cancer

I. Early diagnosis & differential diagnosis of space-occupying lesions.

II. Follow-up & therapeutic outcome & early detection of relapse.

III. Assessment of biological malignancy and prognosis.

IV. Selection of therapeutic interventions.V. Monitoring the patients who are at risk

of developing cancer.

Proteomic Analysis Identifies Breast Cancer Biomarkers in Nipple Aspirate Fluid

NAF from Normal Breast NAF from Cancer Breast

Spot 1= prolactin-induced proteinSpot 2= apolipoprotein DSpot 3= 1-acid glycoprotein

Alexander et al 2004 Clinical Cancer Reseach 10:7500

Identity of spots determined by mass spectrometry

Proteomic Analysis Identifies Breast Cancer Biomarkers in Nipple Aspirate Fluid

Significance of presence of proteins validated bytesting for their presence in the NAFfrom 53 benign breasts and 52 frombreasts with cancer using ELISA (enzyme linked immunosorbant assay) - plate coated with antibodiesto proteins- binding detected by a color reaction.

1-acid glycoprotein levels were higher in women with breast cancer (P=0.002)

Path to Drug Discovery

Principles of Virology, Flint et al

Screening for Antiviral Compounds

Cell based screen - Not Rational Drug Design

mock HIV infected

Drugconc

500 µM

0.16 µM

0 drug

•can assay cytotoxicity and antiviral activity simultaneously•virus replication in cell culture•multiple targets in single screen

•suitable for high-throughput

•follow up studies of active compound more complicated

Selectivity index (SI) =

50% cytotoxic conc. (CC50) 50% inhibitory conc. (IC50)

Cell based screen



Mechanism based screen (Rational)

•Well defined assay for single target•Assays for viral proteases,polymerases, helicases•Need purified protein andspecific substrate•Will not determine cytotoxicity•Amenable to high-throughput - 1536 well trays with µl reactions


Sources of Compounds Used for Screening

•Libraries of chemical compounds (500,000 cmpd)

•Combinatorial librariesall possible combinationsof a basic set of molecular components - tagged microbeadsor chemical supports so activecompounds in mixtures canbe traced and identified easily

•Natural products - diverse mixtures of unknown compoundsfrom plants and marine animals


Structure Based Drug Design

Zanamivir (Relenza) bound to Influenza virus

neuraminidase (NA)

• Zanamivir -Australian designed drugto treat influenza based on 3D structure of viral NA complexed with substrate .•Peter Colman, Mark von Itzstein, Graeme Laver(VCP/CSIRO/ANU/Biota Holdings/GlaxoSmithKline)

•Inhibitor designed to fitin highly conserved deep cavity in NA•Active against influenza A and B•Zanamivir (Relenza) - nasal spray fortherapeutic use and prevention.•Oseltamivir (Tamiflu) - oral formulation(Gilead/Roche) Stockpiled by Australia - against H5N1Avian influenza

Gubareva et al (2000) The Lancet 355:827

Chemical Structures of Neuraminidase Inhibitors

•Neuraminic acid derivativemimics the geometry of thetransition state during theenzymatic reaction

•To increase interactionbetween the substrate andenzyme a guanidinyl groupwas substitued for a hydroxyl group - zanamivir

Neuraminidase Inhibitors Block Influenza ReleaseFrom Cells

Gubareva et al (2000) The Lancet 355:827

saquinavirindinavir

Protease Protease InhibitorsInhibitors

SaquinavirSaquinavir

IndinavirIndinavir

RitonavirRitonavir

NelfinavirNelfinavir

AmprenavirAmprenavir

LopinavirLopinavir

AtazanavirAtazanavir

TipranavirTipranavir

DarunavirDarunavir

Drugs targeting HIV protease

•First inhibitors werepeptidomimetics(mechanism based)

•Based on 7 amino acidsubstrate with noncleavablebond


“Virtual” or “in Silico” Screening•Structure of target must be available

•Identify pockets at functionally important sites (i.e. catalytic site in enzyme or at protein:proteininterface)

•Dock molecules into pocket - libraries available to public

•Order compounds, test in vitro for activity

•Repeat docking

Protein Database

Visualise X ray crystal structure of protein

Define binding site (pocket), setting up a

grid box.

Fit a compound into the pocket (compound is flexible -protein is

rigid)

Score binding energy of each compound

Setting up a grid box

Thousands of compounds

from databases Results sorted by Energy (G-score)

p66

In silico (virtual) screening- an overview

Application in Therapeutic Cancer Vaccines

•A cell membrane glycoprotein Mucin 1 is highly expressed in breast cancer cells

•Mucin 1 shown to induce immune responses in healthy subjects and cancer patients - however responsesare variable and weak.

•Modified immunogenic epitopes of Muc 1 being examined for their capacity to elicit an immune response for useas cancer vaccines (i.e. oxidized mannan-Muc 1)

Acknowledgments

Dr John Lee and A/Prof Mibel Aguilar,Department of Biochemistry and MolecularBiology, Monash University for makingavailable their lecture material for use in thispresentation

Australian Society for Medical Research Australian Society for Medical Research (ASMR) www.asmr.org.au(ASMR) www.asmr.org.au

Peak Professional Society Representing Health and Medical ResearchPeak Professional Society Representing Health and Medical Research - Political, scientific and public advocacy- Political, scientific and public advocacy

Public RelationsPublic Relations– ASMR Medical Research Week: June 4th-8th 2007ASMR Medical Research Week: June 4th-8th 2007

- - Online school quiz for high school students - 20 multiple choicequestions designed to find those students with a good knowledge

in medical science - with prizes for winners ([email protected]) (years 7-9 and years 10-12)(years 7-9 and years 10-12)

– High school visits by Medical ResearchersHigh school visits by Medical Researchers-- Visits to High School Science classes and Career nightsVisits to High School Science classes and Career nights-- Regional “Caravan of Science” ToursRegional “Caravan of Science” Tours

dr gilda tachedjian molecular interactions group dec 2006

Documents